Related Experiment Video
Updated: May 1, 2026

Mouse Round Spermatid Injection
Published on: January 26, 2024
Are human male patients with DAX1/NR0B1 mutations infertile?
Célia Ravel1, Capucine Hyon2, Jean-Pierre Siffroi2
1Service de biologie de la reproduction, hôpital Sud, 35000 Rennes, France.
Abstract:
DAX-1 stands for Dosage sensitive sex-reversal, Adrenal hypoplasia congenital (AHC), on the X chromosome. DAX-1 mutations usually cause primary adrenal insufficiency or congenital adrenal hypoplasia in early childhood and hypogonadotropic hypogonadism (MIM # 300200). DAX-1 protein is necessary to maintain normal spermatogenesis. In humans, male fertility has been studied in few patients carrying DAX-1 mutations. Cases of azoospermia have been reported, as well as unsuccessful gonadotropin treatments. The clinician should be informed that TESE-ICSI technique carries a potential hope to father non-affected children, as shown in this review.
Insights
Mutations in DAX-1 (Dosage sensitive sex-reversal, Adrenal hypoplasia congenital) disrupt male fertility. However, TESE-ICSI offers a potential method for affected individuals to father non-affected children.
Area of Science:
- Genetics
- Endocrinology
- Reproductive Biology
Background:
- DAX-1 (Dosage sensitive sex-reversal, Adrenal hypoplasia congenital) mutations are linked to primary adrenal insufficiency and hypogonadotropic hypogonadism.
- The DAX-1 protein plays a crucial role in maintaining normal spermatogenesis in males.
- Male fertility in individuals with DAX-1 mutations is not well-documented, with reported cases of azoospermia.
Purpose of the Study:
- To review the impact of DAX-1 mutations on male fertility.
- To explore potential reproductive options for men with DAX-1 related infertility.
Main Methods:
- Literature review of clinical cases and genetic studies concerning DAX-1 mutations and male fertility.
- Analysis of reported fertility outcomes and treatment responses in affected individuals.
Main Results:
- DAX-1 mutations are associated with impaired spermatogenesis and azoospermia in affected males.
- Previous treatments, such as gonadotropin therapy, have shown limited success in restoring fertility.
- Testicular Sperm Extraction with Intracytoplasmic Sperm Injection (TESE-ICSI) has emerged as a viable option.
Conclusions:
- DAX-1 mutations significantly impact male reproductive capacity.
- TESE-ICSI presents a promising avenue for achieving biological fatherhood in men with DAX-1 mutations.
- Clinicians should consider TESE-ICSI as a potential treatment for infertility in DAX-1 mutation carriers.
Related Concept Videos
Infertility in Males
The Ratio of X Chromosome to Autosomes
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female...
X-Inactivation
X and Y Chromosomes
The germline cells such as egg and sperm cells carry only half the number of chromosomes, i.e., 22 autosomes and one sex chromosome. All eggs have an X chromosome, while sperm cells can carry an X or...
Nondisjunction
Spermatogenesis

